Cytori Cell Therapy Safe and Potentially Effective in EU Phase I Erectile...
The post Cytori Cell Therapy Safe and Potentially Effective in EU Phase I Erectile Dysfunction Trial appeared first on Cytori Therapeutics, Inc..
View ArticleCytori Provides Latest Corporate Update at Source Capital Conference
The post Cytori Provides Latest Corporate Update at Source Capital Conference appeared first on Cytori Therapeutics, Inc..
View ArticleCytori Reports Interim Data on U.S. Phase II Osteoarthritis Trial
The post Cytori Reports Interim Data on U.S. Phase II Osteoarthritis Trial appeared first on Cytori Therapeutics, Inc..
View ArticleScleroderma Two Year Data to be Presented at the 4th Systemic Sclerosis World...
The post Scleroderma Two Year Data to be Presented at the 4th Systemic Sclerosis World Congress appeared first on Cytori Therapeutics, Inc..
View ArticleJapan Commercial Update
The post Japan Commercial Update appeared first on Cytori Therapeutics, Inc..
View ArticleCytori Management to Discuss Scleroderma Clinical Trial Findings
The post Cytori Management to Discuss Scleroderma Clinical Trial Findings appeared first on Cytori Therapeutics, Inc..
View ArticleData Reports Sustained Benefit at Two Years with Single Administration Cytori...
The post Data Reports Sustained Benefit at Two Years with Single Administration Cytori Cell Therapy for Scleroderma appeared first on Cytori Therapeutics, Inc..
View ArticleCytori Reports Fourth Quarter and Full Year 2015 Business and Financial Results
The post Cytori Reports Fourth Quarter and Full Year 2015 Business and Financial Results appeared first on Cytori Therapeutics, Inc..
View ArticleCytori Granted SME Status by European Medicines Agency
The post Cytori Granted SME Status by European Medicines Agency appeared first on Cytori Therapeutics, Inc..
View ArticleCytori Update on Its U.S. Phase III Scleroderma Trial
The post Cytori Update on Its U.S. Phase III Scleroderma Trial appeared first on Cytori Therapeutics, Inc..
View Article
